We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




First Of Its Kind Blood Test Accurately Predicts Preterm Birth Risk

By LabMedica International staff writers
Posted on 17 Jan 2025
Print article
Image: The test examines how immune cells react to common challenges during pregnancy (Photo courtesy of OSU)
Image: The test examines how immune cells react to common challenges during pregnancy (Photo courtesy of OSU)

Preterm birth is one of the leading causes of childhood mortality worldwide. The World Health Organization reports that over 15 million babies are born prematurely each year, with more than a million of them not surviving. Approximately 70% of preterm births occur spontaneously, without a medical indication. Black mothers are also twice as likely to experience preterm birth compared to White mothers, although the reasons for this disparity remain unclear. Now, a groundbreaking blood test has been developed that may predict the risk of preterm birth early in pregnancy.

Researchers at The Ohio State University (Columbus, OH, USA) developed this new blood test after studying various risk factors for preterm birth, including stressors such as early life adversity and experiences of racial discrimination. They discovered that persistent stress, poor sleep, depression, and anxiety can subtly alter the functioning of the immune system over time. These changes in immune function can be detected with a simple blood test, requiring less than a teaspoon of blood. Initial tests of the blood test show promising potential, with the ability to predict the risk of preterm birth with accuracy as high as 97.5%.

The researchers suggest that the test could be incorporated into the "prenatal battery," a set of screenings designed to help clinicians identify factors that may increase a patient's risk of preterm birth, allowing for early interventions before any symptoms appear. The team is now working to conduct a larger and more comprehensive study to ensure the test's accuracy in diverse patient populations. They are also exploring treatments that could "reset" the immune system’s responses to normal levels to further reduce the risk of preterm birth.

“We’re essentially trying to create this ‘crystal ball’ of future events. We are truly producing a future likely scenario early in pregnancy. And so, if the body’s not responding in the right way, we can see that,” said Shannon Gillespie, PhD, RN, FAAN, assistant professor at Ohio State’s College of Nursing. “It should feel as simple as a test for anemia. So things that can be available for everyone that’s interested.”

New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Malaria Test
STANDARD Q Malaria P.f/Pan Ag
New
Respiratory QC Panel
Assayed Respiratory Control Panel

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.